Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells.
第一作者:
H,Scharnagl
第一单位:
Division of Clinical Chemistry, Department of Medicine, Albert-Ludwigs-University Freiburg, Hugstetter Strabetae 55, 79106, Freiburg, Germany. hubsch@med1.ukl.uni-freiburg.de
作者:
主题词
抗胆固醇血症药(Anticholesteremic Agents);CCAAT增强子结合蛋白类(CCAAT-Enhancer-Binding Proteins);胆固醇(Cholesterol);DNA结合蛋白质类(DNA-Binding Proteins);基因表达(Gene Expression);庚酸类(Heptanoic Acids);人类(Humans);羟甲基戊二酰基CoA还原酶抑制剂(Hydroxymethylglutaryl-CoA Reductase Inhibitors);脂类代谢(Lipid Metabolism);洛伐他汀(Lovastatin);吡咯类(Pyrroles);受体, LDL(Receptors, LDL);斯伐他汀(Simvastatin);胆固醇调节元件结合蛋白质1(Sterol Regulatory Element Binding Protein 1);转录因子(Transcription Factors);甘油三酯类(Triglycerides);肿瘤细胞, 培养的(Tumor Cells, Cultured)
DOI
10.1016/s0006-2952(01)00790-0
PMID
11728391
发布时间
2022-03-16
- 浏览33

Biochemical pharmacology
1545-55页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文